S100B and type 2 diabetes mellitus: In addition, we found that the levels of serum S100B in patients with cognitive impairment in T2DM were negatively correlated with the progression of the disease, suggesting that S100B may undergo changes during the emergence and progression of cognitive impairment in T2DM.